Curaleaf Holdings, Inc.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in New York, NY.

The "if" probably should really be "when."

3 Marijuana Stocks to Buy If New York Legalizes Recreational Pot

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

Village Farms International

GrowGeneration Corp

Looking for marijuana stocks that are poised to heat up this summer? Here are seven top picks for investors to consider now.

7 Marijuana Stocks to Buy That Will Heat Up This Summer

AMC Entertainment

BlackBerry

GameStop

Netflix

Nokia

Zomedica

More stimulus means more money flowing into the stock market. Here are seven meme stocks that may benefit from the government's largesse.

7 Meme Stocks to Buy After the Roblox IPO

Aphria

Canopy Growth

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Tilray Brands

Alpha Trader Talks Cannabis Investing With Todd Harrison (Podcast Transcript)

These two pot stocks have all the qualities of turning your investment around over the long term.

Got $2,000? These 2 Cannabis Growth Stocks Can Make You Rich

Select's Newest High-Quality Cannabis Oil Launch Features Bold Fruit Flavors & New .3 Gram "Go" Cartridge  WAKEFIELD, Mass., March 17, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading U.S. provider of consumer products in cannabis, today announced the latest addition to its suite of products with Select Fresh, which will make history as a THC product initially launched simultaneously across 10 markets.

Curaleaf's Select Brand Introduces "Select Fresh" Line in 10 States

Planet 13 Holdings Inc (CSE:PLTH) (OTCQB:PLNHF), a leading vertically integrated Nevada cannabis company, is partnering with industry giant Curaleaf Holdings Inc.  Curaleaf's popular brand Select, known as America's No 1 Cannabis Oil Brand, has teamed up with Planet 13 to create a unique shop-in-shop experience by highlighting its Select brand in Planet 13's Las Vegas SuperStore.  The shop-in-shop, which will occupy prime space within the Las Vegas SuperStore dispensary, hosts its grand opening March 15 (today) and will be staffed by Select team members, Planet 13 said in a statement.

Planet 13 partners with Curaleaf to open Select brand shop-in-shop in its Las Vegas SuperStore

WAKEFIELD, Mass., March 15, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading U.S. provider of consumer products in cannabis, today announced that Mr.

Curaleaf Appoints Carlos Madrazo as Senior Vice President Investor Relations and Capital Markets

WAKEFIELD, Mass., March 12, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading U.S. provider of consumer products in cannabis, today announced that Joseph Bayern, Curaleaf Chief Executive Officer, will be participating in the Cannabis State of the Industry Panel presentation at the Roth Capital Partners Virtual 33rd Annual Conference for investors on Tuesday, March 16, 2021 at 2:00 pm ET.

Curaleaf Announces Participation in Roth Capital Partners Virtual 33rd Annual Conference

Curaleaf enters the European market with the acquisition of EMMAC Life Sciences.

Curaleaf: Global Cannabis Domination

WAKEFIELD, Mass., March 11, 2021 /PRNewswire/ -- A new survey conducted by Siena College Research Institute on behalf of Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading U.S. provider of consumer products in cannabis, finds 57% of New Yorkers favor a faster rollout of legalized cannabis through the expansion of the current medical market compared to legalization proposals that could take 18 months or longer.

Survey Finds A Majority Of New York Voters Support Accelerated Rollout Of Legalized Cannabis

Chairman Boris Jordan expects change, now that Democrats control the White House and Congress.

Curaleaf Is Upbeat About Cannabis Reform. Here's Why.

The multistate cannabis operator has tremendous growth opportunities both in the U.S. and in Europe.

Curaleaf's Q4 Growth Was Impressive, but 2021 Should Be Even Better

FastForward Innovations Ltd (LON:FFWD) said it has agreed to sell its entire interest in cannabis firm EMMAC Life Sciences as part of a takeover of the investee by North American cannabis consumer products group Curaleaf Holdings Inc (CSE:CURA) (OTCQX:CURLF). The AIM-listed firm said it will sell its 6.7mln shares in EMMAC as well as a £750,000 convertible loan note for around £5.04mln, and that it expects to record a profit from the sale of around £1.9mln compared to the September 2020 carrying value of the equity and cost price of the convertible loan note, and an overall return of 1.86 times its original investment.

FastForward Innovations agrees to sell interest in cannabis firm EMMAC Life Sciences

Curaleaf Holdings' (CURLF) CEO Joe Bayern on Q4 2020 Results - Earnings Call Transcript

Acquisitions helped propel revenue higher, and are sure to continue doing so.

Curaleaf Posts 205% Q4 Revenue Growth, Announces $286 Million Deal for European Peer

CURLF reported 205% revenue growth in its latest quarter. The company has fortified its balance sheet with a $240 million cash infusion from recent equity offerings.

Curaleaf Is Firing On All Cylinders: Blockbuster Earnings, Largest USA Cannabis Company

Cannabis company Curaleaf Holdings Inc. (OTCQX:CURLF) is looking to expand to Europe via M&A. The Wakefield, Massachusetts-based company announced Tuesday that it will acquire one of Europe's largest cannabis companies, EMMAC Life Sciences, for approximately $286 million in cash and stock.

Curaleaf Wields M&A To Tap European Market, Agrees To Buy EMMAC For $286M

WAKEFIELD, Mass., March 9, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading U.S. provider of consumer products in cannabis, today reported its financial and operating results for the fourth quarter and year ended December 31, 2020.

Curaleaf Reports Record Fourth Quarter and Fiscal Year End 2020 Financial and Operational Results

WAKEFIELD, Mass., March 9, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading U.S. provider of consumer products in cannabis, today announced that it has signed a definitive agreement to acquire EMMAC Life Sciences Limited ("EMMAC"), the largest vertically integrated independent cannabis company in Europe for base consideration of approximately US$286 million to be paid 85% in Curaleaf subordinate voting shares and 15% in cash.

Curaleaf to Enter European Cannabis Market with Acquisition of EMMAC Life Sciences Limited - Europe's Leading Independent Cannabis Company

Alpha Trader Talks Cannabis Investing With Todd Harrison (Podcast)

With Q4 results coming this week, this cannabis stock gives investors multiple reasons to buy and hold it.

Ahead of Earnings, Curaleaf's CFO Says Fiscal 2020 Will End on a High Note

Shares of U.S. multi-state cannabis operator Curaleaf Holdings Inc. (OTCQX: CURLF) traded lower by 3.6% on Thursday morning, but one analyst has high hopes for the company's fourth-quarter earnings report next week. The Analyst: On Thursday, Roth Capital Partners analyst Scott Fortune reiterated his Buy rating and $20 price target for Curaleaf.

Analyst Previews Curaleaf Earnings: 'Bellwether Of The U.S. Cannabis Industry'

GW Pharmaceuticals

Jazz Pharmaceuticals

MedMen Enterprises Inc.

OrganiGram Holdings Inc.

SNDL Inc.

Each of these cannabis stocks blazed higher by between 20% and 208% last month.

The 10 Best Marijuana Stocks in February

The cannabis producer has been one of the hottest buys in the industry over the past year.

Is Curaleaf Stock a Buy?

News for Curaleaf Holdings, Inc. Stock (CURLF)